150 related articles for article (PubMed ID: 31633867)
1. The atherogenic role of immune cells in familial hypercholesterolemia.
Taghizadeh E; Taheri F; Gheibi Hayat SM; Montecucco F; Carbone F; Rostami D; Montazeri A; Sahebkar A
IUBMB Life; 2020 Apr; 72(4):782-789. PubMed ID: 31633867
[TBL] [Abstract][Full Text] [Related]
2. Oxidative burden in familial hypercholesterolemia.
Mollazadeh H; Carbone F; Montecucco F; Pirro M; Sahebkar A
J Cell Physiol; 2018 Aug; 233(8):5716-5725. PubMed ID: 29323716
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
4. Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia.
Christensen JJ; Osnes LT; Halvorsen B; Retterstøl K; Bogsrud MP; Wium C; Svilaas A; Narverud I; Ulven SM; Aukrust P; Holven KB
Atherosclerosis; 2017 Jan; 256():67-74. PubMed ID: 28024183
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia.
Bahrami A; Liberale L; Reiner Ž; Carbone F; Montecucco F; Sahebkar A
Rev Physiol Biochem Pharmacol; 2020; 177():25-52. PubMed ID: 32691159
[TBL] [Abstract][Full Text] [Related]
6. Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins.
Escate R; Padro T; Borrell-Pages M; Suades R; Aledo R; Mata P; Badimon L
J Cell Mol Med; 2017 Mar; 21(3):487-499. PubMed ID: 27680891
[TBL] [Abstract][Full Text] [Related]
7. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.
Narverud I; Retterstøl K; Iversen PO; Halvorsen B; Ueland T; Ulven SM; Ose L; Aukrust P; Veierød MB; Holven KB
Atherosclerosis; 2014 Aug; 235(2):299-309. PubMed ID: 24908240
[TBL] [Abstract][Full Text] [Related]
8. Variation in Coronary Atherosclerosis Severity Related to a Distinct LDL (Low-Density Lipoprotein) Profile: Findings From a Familial Hypercholesterolemia Pig Model.
Hoogendoorn A; den Hoedt S; Hartman EMJ; Krabbendam-Peters I; Te Lintel Hekkert M; van der Zee L; van Gaalen K; Witberg KT; Dorst K; Ligthart JMR; Drouet L; Van der Heiden K; van Lennep JR; van der Steen AFW; Duncker DJ; Mulder MT; Wentzel JJ
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2338-2352. PubMed ID: 31554418
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
[TBL] [Abstract][Full Text] [Related]
10. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
[TBL] [Abstract][Full Text] [Related]
11. Intracellular cholesterol accumulation and coenzyme Q
Suárez-Rivero JM; de la Mata M; Pavón AD; Villanueva-Paz M; Povea-Cabello S; Cotán D; Álvarez-Córdoba M; Villalón-García I; Ybot-González P; Salas JJ; Muñiz O; Cordero MD; Sánchez-Alcázar JA
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3697-3713. PubMed ID: 30292637
[TBL] [Abstract][Full Text] [Related]
12. Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment.
Holven KB; Narverud I; Lindvig HW; Halvorsen B; Langslet G; Nenseter MS; Ulven SM; Ose L; Aukrust P; Retterstøl K
Atherosclerosis; 2014 Apr; 233(2):561-567. PubMed ID: 24530965
[TBL] [Abstract][Full Text] [Related]
13. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
14. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia.
Hjuler Nielsen M; Irvine H; Vedel S; Raungaard B; Beck-Nielsen H; Handberg A
PLoS One; 2015; 10(4):e0121516. PubMed ID: 25875611
[TBL] [Abstract][Full Text] [Related]
15. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
Ooi EM; Barrett PH; Watts GF
Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.
Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB
Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918
[TBL] [Abstract][Full Text] [Related]
17. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis.
Aliev G; Burnstock G
Histol Histopathol; 1998 Jul; 13(3):797-817. PubMed ID: 9690137
[TBL] [Abstract][Full Text] [Related]
18. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
[TBL] [Abstract][Full Text] [Related]
19. Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.
Wang J; He K; Yang C; Lin X; Zhang X; Wang Y; Liu G; Xian X
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323736
[TBL] [Abstract][Full Text] [Related]
20. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname MH; Santos RD
Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
